Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gleason

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JMIR Aging|December 17, 2024
Improving How Caregivers of People Living With Dementia Are Identified in the Electronic Health Record: Qualitative Study and Exploratory Chart ReviewAriel R Green, Cynthia M Boyd, Rosalphie Quiles Rosado, et al.
Journal of General Internal Medicine|July 31, 2020
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative StudyAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Journal of General Internal Medicine|January 12, 2021
Perspectives on Deprescribing Communication in Primary CareAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Passive accumulation of alkaloids in inconspicuously colored frogs refines the evolutionary paradigm of acquired chemical defensesRebecca D Tarvin, Jeffrey L Coleman, David A Donoso, et al.
Elife|December 27, 2024
Passive accumulation of alkaloids in inconspicuously colored frogs refines the evolutionary paradigm of acquired chemical defensesRebecca D Tarvin, Jeffrey L Coleman, David A Donoso, et al.
Journal of the American Geriatrics Society|December 12, 2022
Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trialOrla C Sheehan, Kathy S Gleason, Elizabeth A Bayliss, et al.
Patient Education and Counseling|October 22, 2025
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trialElizabeth A Bayliss, Kathy S Gleason, Orla C Sheehan, et al.
Trials|June 20, 2020
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trialE A Bayliss, S M Shetterly, M L Drace, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JMIR Aging|December 17, 2024
Improving How Caregivers of People Living With Dementia Are Identified in the Electronic Health Record: Qualitative Study and Exploratory Chart ReviewAriel R Green, Cynthia M Boyd, Rosalphie Quiles Rosado, et al.
Journal of General Internal Medicine|July 31, 2020
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative StudyAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Journal of General Internal Medicine|January 12, 2021
Perspectives on Deprescribing Communication in Primary CareAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Passive accumulation of alkaloids in inconspicuously colored frogs refines the evolutionary paradigm of acquired chemical defensesRebecca D Tarvin, Jeffrey L Coleman, David A Donoso, et al.
Elife|December 27, 2024
Passive accumulation of alkaloids in inconspicuously colored frogs refines the evolutionary paradigm of acquired chemical defensesRebecca D Tarvin, Jeffrey L Coleman, David A Donoso, et al.
Journal of the American Geriatrics Society|December 12, 2022
Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trialOrla C Sheehan, Kathy S Gleason, Elizabeth A Bayliss, et al.
Patient Education and Counseling|October 22, 2025
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trialElizabeth A Bayliss, Kathy S Gleason, Orla C Sheehan, et al.
Trials|June 20, 2020
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trialE A Bayliss, S M Shetterly, M L Drace, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Pageof 5